Will Weight Loss Injections Cause Loose Skin?

The myth: weight loss injections are especially likely to cause loose skin

This concern comes up often, and it usually rests on a category error. The worry isn't really about the injection — it's about the weight loss itself. Any method that produces significant loss can result in some laxity, because skin is a living organ that reshapes slowly. The leap to blaming the medicine tends to follow stories about dramatic results seen quickly; but compared with very-low-calorie diets or some surgical programmes, the reduction profile from GLP-1 medicines tends to be more gradual.

In the SURMOUNT-1 clinical trial, participants taking the highest tirzepatide dose achieved an average body-weight reduction of around 20–21% over 72 weeks, roughly 16–18 months. That timeline gives connective tissue considerably longer to respond than a rapid crash programme would. The NHS medicines page on tirzepatide confirms the treatment is used alongside lifestyle changes, which themselves support slower, more sustainable loss.

None of this is a guarantee that loose skin won't occur. If you carry a lot of excess weight, some laxity after large loss is common regardless of method. But attributing it specifically to the injection, which works by regulating appetite and blood sugar through GLP-1 receptor pathways, misunderstands what's actually happening under the skin.

What actually determines whether loose skin develops

Several factors interact, most of them outside anyone's control. Age is the biggest one. Skin produces less collagen and elastin as we get older, so it bounces back less readily after significant volume loss. Genetics, how long excess weight has been carried, sun exposure history and smoking status all play a role too.

What can be influenced is the pace of loss and body composition during it. Muscle acts as a structural layer beneath the skin; people who maintain or build muscle while losing fat tend to find the result looks and feels firmer. This is why prescribers who work in weight management routinely encourage protein adequacy (often 1.2–1.6 g per kilogram of target body weight) and resistance training alongside GLP-1 treatment. A useful overview of how these medicines support weight management is on our page on how weight loss injections work.

Hydration matters too, both for skin health and for managing the gastrointestinal side effects that some people experience early in treatment. The skin doesn't operate in isolation from the rest of the body's physiology.

Patience, not panic: the post-loss adaptation window

Skin continues adapting for a significant period after weight stabilises, commonly cited as 12 to 24 months, though individual variation is wide. Clinicians who assess loose skin for any intervention will usually advise waiting until weight has been stable for at least a year before drawing conclusions about what remains.

This is relevant for anyone on a GLP-1 medicine who notices laxity mid-treatment or shortly after reaching their target. What you see at six months is not the final picture. Many people find that continuing to build muscle, staying hydrated, and giving the skin time produces a noticeably different result a year later.

If laxity remains significant after that period, the options range from targeted exercise to non-surgical procedures and, in cases of substantial excess skin that causes physical problems, surgical removal. Those conversations belong with a GP, dermatologist or plastic surgeon, a prescriber at a weight-loss clinic can point you in the right direction but wouldn't make that call. You can find out how our clinicians approach ongoing support on the about us page.

It's also worth knowing that the NICE appraisal of tirzepatide (TA1026) recommends the medicine for adults with a BMI of 35 or above plus at least one weight-related condition, but private eligibility through a regulated pharmacy like ours follows the licensed criteria, which are somewhat broader. A prescriber makes that assessment individually, taking the full clinical picture into account.

What you can do practically, starting now

A few habits make a material difference during treatment. Getting enough protein at each meal is easier if you plan it before appetite suppression kicks in, many people on GLP-1 medicines find they're simply not hungry enough to eat well without intention. Two or three resistance sessions a week, even bodyweight exercises at home, preserve the muscle mass that supports skin structure.

Storage is a small but practical consideration: your pen lives in the fridge door, and pulling it out 30 minutes before your weekly injection brings it to room temperature, which many people find more comfortable. That minute of planning is a useful prompt to also drink a glass of water, hydration supports both side-effect management and skin health.

For a broader look at the treatment options available, the weight loss treatments page sets out what's clinically assessed at consultation. And if you're curious about how the three licensed weight loss injections compare on outcomes and mechanisms, our weight loss injections overview covers both tirzepatide and semaglutide in detail. Questions about what to expect in the first weeks are also addressed in our FAQs.

If you'd like to discuss how treatment might fit your specific situation, you can buy weight loss injections through our pharmacy after a free consultation that is clinically led and reviewed by a GPhC-registered Independent Prescriber the same day. Patients who are eligible through their NHS provider may also want to review our guidance on the right to choose weight loss injections, which explains how that pathway works alongside private options.